1197375-23-7 Usage
Uses
Used in Pharmaceutical Applications:
(3S)-3-(2-Thienylthio)butanoic acid compd. with (alphaR)-alpha-methylbenzenemethanamine is used as a pharmaceutical agent for its potential biological activity. The individual components of the compound are known for their biological properties, which may contribute to the development of new drugs or therapeutic agents.
Used in Chemical Synthesis:
In the chemical industry, (3S)-3-(2-Thienylthio)butanoic acid compd. with (alphaR)-alpha-methylbenzenemethanamine can be used as a building block or intermediate in the synthesis of more complex organic compounds. Its unique structure, including the thienylthio group and the (alphaR)-alpha-methylbenzenemethanamine molecule, may offer new opportunities for the development of novel chemical products.
Used in Material Science:
(3S)-3-(2-Thienylthio)butanoic acid compd. with (alphaR)-alpha-methylbenzenemethanamine may also find applications in material science, where its unique structure and properties could be utilized in the development of new materials with specific characteristics. For example, it could be used in the synthesis of polymers, coatings, or other materials with tailored properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1197375-23-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,7,3,7 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1197375-23:
(9*1)+(8*1)+(7*9)+(6*7)+(5*3)+(4*7)+(3*5)+(2*2)+(1*3)=187
187 % 10 = 7
So 1197375-23-7 is a valid CAS Registry Number.
1197375-23-7Relevant academic research and scientific papers
Process for obtaining 4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide and its enantiomers, and applications thereof
-
Page/Page column 9, (2009/12/23)
The invention relates to a process for obtaining cis-4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide, its enantiomers or mixtures thereof, by reduction of 5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one-7,7-dioxide with a reducing agent which generates hydride ions. The obtained compounds are useful as intermediates in the synthesis of chiral active ingredients.
